Shire Pharmaceuticals Group plc, Structural GenomiX deal

Structural acquired worldwide rights to SHP's Troxatyl dioxolane nucleoside analog, which is in Phase I/II testing to treat acute myelogenous leukemia (AML) and solid tumors. Structural plans to start...